335 related articles for article (PubMed ID: 23118779)
1. Initiation and regulation of complement during hemolytic transfusion reactions.
Stowell SR; Winkler AM; Maier CL; Arthur CM; Smith NH; Girard-Pierce KR; Cummings RD; Zimring JC; Hendrickson JE
Clin Dev Immunol; 2012; 2012():307093. PubMed ID: 23118779
[TBL] [Abstract][Full Text] [Related]
2. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
Roumenina LT; Bartolucci P; Pirenne F
Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them.
Beauregard P; Blajchman MA
Transfus Med Rev; 1994 Jul; 8(3):184-99. PubMed ID: 8081080
[No Abstract] [Full Text] [Related]
4. Role of complement in alloimmunization and hyperhemolysis.
Chonat S; Mener A; Verkerke H; Stowell SR
Curr Opin Hematol; 2020 Nov; 27(6):406-414. PubMed ID: 32889827
[TBL] [Abstract][Full Text] [Related]
5. Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.
Arthur CM; Chonat S; Fasano R; Yee MEM; Josephson CD; Roback JD; Stowell SR
Transfus Med Rev; 2019 Oct; 33(4):217-224. PubMed ID: 31679762
[TBL] [Abstract][Full Text] [Related]
6. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
[TBL] [Abstract][Full Text] [Related]
7. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
Irani MS; Karafin MS; Ernster L
J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
[TBL] [Abstract][Full Text] [Related]
8. Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange.
Tormey CA; Stack G
Arch Pathol Lab Med; 2013 Jun; 137(6):861-4. PubMed ID: 23721278
[TBL] [Abstract][Full Text] [Related]
9. Complement inhibitors to treat IgM-mediated autoimmune hemolysis.
Wouters D; Zeerleder S
Haematologica; 2015 Nov; 100(11):1388-95. PubMed ID: 26521297
[TBL] [Abstract][Full Text] [Related]
10. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.
Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY
Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226
[TBL] [Abstract][Full Text] [Related]
11. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
[TBL] [Abstract][Full Text] [Related]
12. Hemolysis from ABO Incompatibility.
Simmons DP; Savage WJ
Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of hemolytic transfusion reactions.
Davenport RD
Semin Hematol; 2005 Jul; 42(3):165-8. PubMed ID: 16041666
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell transfusion in patients with anti-Yt
Wong SM; Cawthorne T; Dennington PM; Hong FS
Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
[TBL] [Abstract][Full Text] [Related]
15. Prevention of complement-mediated immune hemolysis by a small molecule compound.
Mqadmi A; Zheng X; Song J; Abramowitz S; Giclas P; Yazdanbakhsh K
Biochem Biophys Res Commun; 2004 Dec; 325(4):1465-71. PubMed ID: 15555593
[TBL] [Abstract][Full Text] [Related]
16. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
Berséus O; Boman K; Nessen SC; Westerberg LA
Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
[TBL] [Abstract][Full Text] [Related]
17. Strong T-transformation associated with a severe haemolytic reaction in a young infant transfused with packed red cells.
Mullard GW; Thompson IH; Lee D; Owen WG
Clin Lab Haematol; 1981; 3(4):357-64. PubMed ID: 7333066
[No Abstract] [Full Text] [Related]
18. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
20. [The risk of post-transfusion hemolytic complications in rhesus-positive patients and the ways of their prevention].
Dizik GM; Pavliuk RP
Klin Khir; 2011 Sep; (9):69-72. PubMed ID: 22168031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
